Stockreport

Cadrenal Therapeutics to Present at the Emerging Growth Conference on June 12, 2024 [Yahoo! Finance]

Cadrenal Therapeutics, Inc.  (CVKD) 
PDF late-stage, new-generation Vitamin K Antagonist (VKA) oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blo [Read more]